Circulation

RT/follows do not imply endorsement.

[Circulation @CircAHA]

@POsmancik
@VivekReddyMD

[Circulation @CircAHA]

In this sham-controlled trial of 60 patients with symptomatic atrial fibrillation, pulsed field ablation (PFA) was superior to sham in reducing arrhythmia recurrence & burden and improving QOL. https://t.co/iZqzeZILK7

[Circulation @CircAHA]

@GOuditResearch
@sanjaydivakaran
@yurikim_mdphd
@MerajNeyazi @vent_gabriela

[Circulation @CircAHA]

Integrated single-nuclei and spatial mapping of cardiac sarcoidosis reveal inflammatory niches and clonal B-cell autoimmunity. https://t.co/LS5db1ADTC

[Circulation @CircAHA]

@GalTsaban
@liav_alufer

[Circulation @CircAHA]

Lifestyle intervention-induced visceral adipose tissue (VAT) loss may persist despite weight regain and confer lasting cardiometabolic benefits: VAT loss, not weight loss, may be the key target for durable cardiometabolic health. https://t.co/uHef45YF0d

[Circulation @CircAHA]

Upregulated BACH1 is involved in pulmonary hypertension pathogenic mechanisms. BACH1 inhibition may be a novel therapeutic strategy for idiopathic PAH @eosto1 @jiayi Lin https://t.co/dc5Ou5jyWB

[Circulation @CircAHA]

NAP is a key circulating metabolite linking intestinal injury to cardiac toxicity and provides a potential biomarker for monitoring cardiovascular risk in microplastic exposed populations. https://t.co/YePUpEJJvJ

[Circulation @CircAHA]

Co-published by @ACPinternists and @AHAScience #AHAJournals, @AnnalsofIMCC is a peer-reviewed, open access journal that publishes #casereports, case series, and image/video cases across the spectrum of medicine. Learn more and submit to AIMCC today at https://t.co/IzoNqdQ2Qo

[Circulation @CircAHA]

Role of Physical Activity in Obesity Treatment and Cardiometabolic Health
https://t.co/MhD2zw7g7c

[Circulation @CircAHA]

#ICYMI: AI-Echo to Detect Congenital Heart Disease @jmayour @sgcard

[Circulation @CircAHA]

#SimPub #ACC26 AI-driven echo interpretation for congenital heart disease: EchoFocus-CHD detected critical CHD with excellent performance. A potential to bring expert-level pediatric cardiology to r... https://t.co/r6dmUP3DBy @jmayour @DanielleSganga @FraSperotto @sgcard @lacava

[Circulation @CircAHA]

#ICYMI: Mechanisms of MINOCA @nyulangone
@BaineyKevin @SripalBangalore
@yadersandoval @aklfahed
@HashimHayder

[Circulation @CircAHA]

#SimPub #ACC26 OCT + cardiac MRI identified a diagnosis in 79% of MINOCA patients: true MI in 59%, mimic in 20%. Clinical factors poorly predicted imaging findings, emphasizing ... @BaineyKevin @SripalBangalore @yadersandoval @aklfahed @HashimHayder https://t.co/Xe6PmGEsIO

[Circulation @CircAHA]

#ICYMI: Recovery from Heart Failure @hfdocbhimaraj
@kaifu3

[Circulation @CircAHA]

LVAD support enhances heart recovery by boosting capillaries, reducing fibrosis, and driving fibroblast-to-endothelial switching via c-Myc, revealing new regenerative pathways for HF therapy.🫀@hfdocbhimaraj @kaifu3 @na https://t.co/YaiyqEu5CU

[Circulation @CircAHA]

#ICYMI: PRMT3-PCSK9 axis amplifies CAVD

[Circulation @CircAHA]

PRMT3-mediated arginine methylation stabilizes PCSK9 and promote aortic valve calcification. Selective inhibition of PRMT3 can be a new non-invasive therapeutic strategy to slow or prevent progression of calcific aortic valve disease.https://t.co/LEQ3K6VwCd

[Circulation @CircAHA]

@AOskar
@AndreasRck2
@phillipfreeman
@MuhammadSabbah2
@JasmineMarquard
@AshkanEftekhar1
@cglinge

[Circulation @CircAHA]

#ResearchLetter: In this sub study from the NOTION-3 randomized trial, baseline angina did not modify the relative effect of PCI vs. OMT in patients undergoing TAVI with significant CAD. https://t.co/aRXp86Nga7

[Circulation @CircAHA]

@GBarnesMD
@AnticoagPharmD
@AAllenPharmD

[Circulation @CircAHA]

Anticoagulation stewardship care mode: population health approach to identify pts likely to benefit from pharmacist engagement. Other CV medication stewardship services can integrate similar dashboards, alerts, risk stratification algorithms https://t.co/00RvTwhDQu

[Circulation @CircAHA]

@RonBlankstein
@rgiuglaino
@marstonMD
@averkov
@Vmonguillon
@DrM_ODonoghue

[Circulation @CircAHA]

#JustPublished: Lp(a), Evolocumab & First Major Coronary Event https://t.co/vTZNqlOR3f